<bill session="109" type="h" number="3546" updated="2023-01-13T04:50:31Z">
  <state datetime="2005-07-28">REFERRED</state>
  <status>
    <introduced datetime="2005-07-28"/>
  </status>
  <introduced datetime="2005-07-28"/>
  <titles>
    <title type="display">Prescription Drug Pricing and Medicaid Fraud Prevention Act of 2005</title>
    <title type="official" as="introduced">To amend title XIX of the Social Security Act to provide for public disclosure of average manufacturer prices (AMP) and best prices for prescription drugs.</title>
    <title type="short" as="introduced">Prescription Drug Pricing and Medicaid Fraud Prevention Act of 2005</title>
  </titles>
  <sponsor bioguide_id="E000287"/>
  <cosponsors>
    <cosponsor bioguide_id="B000420" joined="2005-09-20"/>
    <cosponsor bioguide_id="C001055" joined="2005-07-28"/>
    <cosponsor bioguide_id="C000714" joined="2005-09-27"/>
    <cosponsor bioguide_id="D000399" joined="2005-07-28"/>
    <cosponsor bioguide_id="F000030" joined="2005-12-13"/>
    <cosponsor bioguide_id="H001037" joined="2005-07-28"/>
    <cosponsor bioguide_id="H000627" joined="2005-10-06"/>
    <cosponsor bioguide_id="L000563" joined="2005-07-28"/>
    <cosponsor bioguide_id="M000309" joined="2005-09-06"/>
    <cosponsor bioguide_id="M000404" joined="2005-12-16"/>
    <cosponsor bioguide_id="M000590" joined="2005-09-27"/>
    <cosponsor bioguide_id="O000159" joined="2005-09-27"/>
    <cosponsor bioguide_id="S000033" joined="2005-12-13"/>
    <cosponsor bioguide_id="S001153" joined="2005-09-27"/>
    <cosponsor bioguide_id="W000314" joined="2005-10-20"/>
    <cosponsor bioguide_id="W000738" joined="2005-12-13"/>
  </cosponsors>
  <actions>
    <action datetime="2005-07-28">
      <text>Introduced in House</text>
    </action>
    <action datetime="2005-07-28" state="REFERRED">
      <text>Referred to the House Committee on Energy and Commerce.</text>
    </action>
    <action datetime="2005-08-05">
      <text>Referred to the Subcommittee on Health.</text>
    </action>
  </actions>
  <committees>
    <committee code="HSIF" name="House Energy and Commerce" subcommittee="" activity="Referral"/>
    <committee code="HSIF14" name="House Energy and Commerce" subcommittee="Health" activity="Referral"/>
  </committees>
  <relatedbills/>
  <subjects>
    <term name="Health"/>
    <term name="Business records"/>
    <term name="Commerce"/>
    <term name="Drug industry"/>
    <term name="Drugs"/>
    <term name="Government Operations and Politics"/>
    <term name="Government publicity"/>
    <term name="Medicaid"/>
    <term name="Prescription pricing"/>
    <term name="Rebates"/>
    <term name="Social Welfare"/>
  </subjects>
  <amendments/>
  <summary date="2005-10-13T16:29:12Z" status="Introduced in House">Prescription Drug Pricing and Medicaid Fraud Prevention Act of 2005 - Amends title XIX (Medicaid) of the Social Security Act to require the Secretary of Health and Human Services to disclose publicly the average manufacturer prices (AMP) and best prices for prescription drugs.

Requires each drug manufacturer with a rebate agreement in effect to report to the Secretary detailed information (specified by the Secretary) on how the AMP is computed, including assumptions used.</summary>
</bill>
